Insulin degludec/insulin aspart safely improves HbA1c: A long-term real-world cohort study (IDEA)

被引:2
作者
Kesavadev, Jothydev [1 ]
Saboo, Banshi [2 ]
Kovil, Rajiv [3 ]
Joshi, Shashank [4 ]
Shankar, Arun [1 ]
Ashik, Asha [5 ]
Ashok, Ashwin David [6 ]
Basanth, Anjana [7 ]
Krishnan, Gopika [7 ]
机构
[1] Jothydevs Diabet Res Ctr, Dept Diabet, Trivandrum 695032, Kerala, India
[2] Diacare Diabet Hormone Clin, Dept Diabetol, Ahmadabad, Gujarat, India
[3] Dr Kovils Diabet Care Ctr, Mumbai, Maharashtra, India
[4] Lilavati Hosp & Res Ctr, Mumbai, Maharashtra, India
[5] Jothydevs Diabet Res Ctr, Dept Diabet, Kochi, India
[6] Jothydevs Diabet Res Ctr, Dept Diabet, Attingal, India
[7] Jothydevs Diabet Res Ctr, Trivandrum, Kerala, India
关键词
glycaemic control; hypoglycaemia; insulin therapy; type; 2; diabetes;
D O I
10.1111/dom.14847
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:306 / 309
页数:4
相关论文
共 10 条
[1]   A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use [J].
Haahr, Hanne ;
Fita, Edmond G. ;
Heise, Tim .
CLINICAL PHARMACOKINETICS, 2017, 56 (04) :339-354
[2]  
International Diabetes Federation, IDF DIABETES ATLAS
[3]   Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes [J].
Inzucchi, Silvio E. ;
Bergenstal, Richard M. ;
Buse, John B. ;
Diamant, Michaela ;
Ferrannini, Ele ;
Nauck, Michael ;
Peters, Anne L. ;
Tsapas, Apostolos ;
Wender, Richard ;
Matthews, David R. .
DIABETOLOGIA, 2015, 58 (03) :429-442
[4]  
Kalra Sanjay, 2016, Indian J Endocrinol Metab, V20, P369, DOI 10.4103/2230-8210.177416
[5]   Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naive Patients with Type 2 Diabetes: A Randomized Controlled Trial [J].
Kumar, Ajay ;
Franek, Edward ;
Wise, Jonathan ;
Niemeyer, Marcus ;
Mersebach, Henriette ;
Simo, Rafael .
PLOS ONE, 2016, 11 (10)
[6]   Ten Years of Experience with Biphasic Insulin Aspart 30 From Drug Development to the Latest Clinical Findings [J].
Liebl, Andreas ;
Prusty, Vinay ;
Valensi, Paul ;
Kawamori, Ryuzo ;
Christiansen, Jens Sandahl ;
Palmer, Andrew J. ;
Balschmidt, Per ;
Ligthelm, Robert ;
Mohan, Viswanathan .
DRUGS, 2012, 72 (11) :1495-1520
[7]   Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: a randomised trial [J].
Niskanen, Leo ;
Leiter, Lawrence A. ;
Franek, Edward ;
Weng, Jianping ;
Damci, Taner ;
Munoz-Torres, Manuel ;
Donnet, Jean-Paul ;
Endahl, Lars ;
Skjoth, Trine Vang ;
Vaag, Allan .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 167 (02) :287-294
[8]   Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus [J].
Philis-Tsimikas, A. ;
Astamirova, K. ;
Gupta, Y. ;
Haggag, A. ;
Roula, D. ;
Bak, B. A. ;
Fita, E. G. ;
Nielsen, A. M. ;
Demir, T. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 147 :157-165
[9]   Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].
Turner, RC ;
Holman, RR ;
Cull, CA ;
Stratton, IM ;
Matthews, DR ;
Frighi, V ;
Manley, SE ;
Neil, A ;
McElroy, K ;
Wright, D ;
Kohner, E ;
Fox, C ;
Hadden, D ;
Mehta, Z ;
Smith, A ;
Nugent, Z ;
Peto, R ;
Adlel, AI ;
Mann, JI ;
Bassett, PA ;
Oakes, SF ;
Dornan, TL ;
Aldington, S ;
Lipinski, H ;
Collum, R ;
Harrison, K ;
MacIntyre, C ;
Skinner, S ;
Mortemore, A ;
Nelson, D ;
Cockley, S ;
Levien, S ;
Bodsworth, L ;
Willox, R ;
Biggs, T ;
Dove, S ;
Beattie, E ;
Gradwell, M ;
Staples, S ;
Lam, R ;
Taylor, F ;
Leung, L ;
Carter, RD ;
Brownlee, SM ;
Fisher, KE ;
Islam, K ;
Jelfs, R ;
Williams, PA ;
Williams, FA ;
Sutton, PJ .
LANCET, 1998, 352 (9131) :837-853
[10]   Diabetes in South Asians: Is the Phenotype Different? [J].
Unnikrishnan, Ranjit ;
Anjana, Ranjit Mohan ;
Mohan, Viswanathan .
DIABETES, 2014, 63 (01) :53-55